Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: Vitamin D as a possible explanation

European Journal of Cancer

Volumn 43, Issue 11, 2007, Pages 1701-1712

  Tuohimaa, Pentti ^a   Pukkala, Eero ^b   Scélo, Ghislaine ^c   Olsen, Jorgen H ^d   Brewster, David H ^e   Hemminki, Kari ^f,g   Tracey, Elizabeth ^h   Weiderpass, Elisabete ^g,i   Kliewer, Erich V ^j,k   Pompe Kirn, Vera ^l   McBride, Mary L ^m   Martos, Carmen ⁿ   Chia, Kee Seng ^o   Tonita, Jon M ^p   Jonasson, Jon G ^q,r   Boffetta, Paolo ^c   Brennan, Paul ^c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e INFORMATION SERVICES DIVISION   (United Kingdom)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g KAROLINSKA INSTITUTE   (Sweden)

^h New South Wales Cancer Registry   (Australia)

ⁱ CANCER REGISTRY OF NORWAY   (Norway)

^j Epidemiology and Cancer Registry   (Canada)

^k UNIVERSITY OF MANITOBA   (Canada)

^l INSTITUTE OF ONCOLOGY   (Slovenia)

^m BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁿ Cancer Registry of Zaragoza   (Spain)

^o Singapore Cancer Registry   (Singapore)

^p SASKATCHEWAN CANCER AGENCY   (Canada)

^q ICELANDIC CANCER REGISTRY   (Iceland)

^r UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

Epidemiology; Prevention; Second cancer; Skin cancer; Solar UV B; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; COLORECTAL CANCER; CONFIDENCE INTERVAL; FEMALE; GALLBLADDER CANCER; HUMAN; KIDNEY CANCER; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTECTION; SECOND CANCER; SKIN CANCER; SOLAR RADIATION; SOLID TUMOR; STOMACH CANCER; SUN EXPOSURE; SUNBURN;

ADULT; AGED; CARCINOMA, BASAL CELL; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT; VITAMIN D;

EID: 34447317556     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.04.018     Document Type: Article

References (43)

1. Veierod M.B., Weiderpass E., Thorn M., Hansson J., Lund E., Armstrong B., et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 95 20 (2003) 1530-1538
2. Goldberg L.H. Basal cell carcinoma. Lancet 347 9002 (1996) 663-667
3. de Gruijl F.R. Photocarcinogenesis: UVA vs. UVB radiation. Skin Pharmacol Appl Skin Physiol 15 5 (2002) 316-320
4. Magnus K. The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer 47 1 (1991) 12-19
5. Freedman D.M., Dosemeci M., and McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 59 4 (2002) 257-262
6. Garland C.F., and Garland F.C. Do sunlight and vitamin D reduce the likelihood of colon cancer?. Int J Epidemiol 9 3 (1980) 227-231
7. Garland F.C., Garland C.F., Gorham E.D., and Young J.F. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19 6 (1990) 614-622
8. Garland C.F., Garland F.C., and Gorham E.D. Can colon cancer incidence and death rates be reduced with calcium and vitamin D?. Am J Clin Nutr 54 1 Suppl (1991) 193S-201S
9. Grant W.B. Calcium, lycopene, vitamin D and prostate cancer. Prostate 42 3 (2000) 243
10. Grant W.B. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94 6 (2002) 1867-1875
11. Tangrea J., Helzlsouer K., Pietinen P., et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Cause Control 8 4 (1997) 615-625
12. Braun M.M., Helzlsouer K.J., Hollis B.W., and Comstock G.W. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Cause Control 6 3 (1995) 235-239
13. Platz E.A., Leitzmann M.F., Hollis B.W., Willett W.C., and Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Cause Control 15 3 (2004) 255-265
14. Schwartz G.G., and Hulka B.S. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10 5A (1990) 1307-1311
15. Hanchette C.L., and Schwartz G.G. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70 12 (1992) 2861-2869
16. Corder E.H., Guess H.A., Hulka B.S., et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2 5 (1993) 467-472
17. Ma J., Stampfer M.J., Gann P.H., et al. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 7 5 (1998) 385-390
18. Ahonen M.H., Tenkanen L., Teppo L., Hakama M., and Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Cause Control 11 9 (2000) 847-852
19. Luscombe C.J., Fryer A.A., French M.E., et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 358 9282 (2001) 641-642
20. Tuohimaa P., Tenkanen L., Ahonen M., et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108 1 (2004) 104-108
21. Robsahm T.E., Tretli S., Dahlback A., and Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Cause Control 15 2 (2004) 149-158
22. Chen T.C., and Holick M.F. Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab 14 9 (2003) 423-430
23. Miller G.J. Vitamin D and prostate cancer: biologic interactions and clinical potentials. Cancer Metast Rev 17 4 (1998) 353-360
24. Garland C.F., Garland F.C., and Gorham E.D. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci 889 (1999) 107-119
25. Feskanich D., Ma J., Fuchs C.S., et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13 9 (2004) 1502-1508
26. Grau M.V., Baron J.A., Sandler R.S., et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95 23 (2003) 1765-1771
27. Hughes A.M., Armstrong B.K., Vajdic C.M., et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 112 5 (2004) 865-871
28. Gardner M.J., and Altman D.G. Using confidence intervals. Lancet 1 8535 (1987) 746
29. Rusthoven J.J. The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma. Eur J Cancer 34 Suppl. 3 (1998) S31-S36
30. Milan T., Pukkala E., Verkasalo P.K., et al. Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer 87 2 (2000) 283-288
31. Levi F., La Vecchia C., Te V.C., Randimbison L., and Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 147 8 (1998) 722-726
32. Frisch M., Hjalgrim H., Olsen J.H., and Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Int Med 125 10 (1996) 815-821
33. Frisch M., and Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 141 10 (1995) 916-922
34. Termorshuizen F., Garssen J., Norval M., et al. A review of studies on the effects of ultraviolet irradiation on the resistance to infections: evidence from rodent infection models and verification by experimental and observational human studies. Int Immunopharmacol 2 2-3 (2002) 263-275
35. Adami J., Frisch M., Yuen J., Glimelius B., and Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 310 6993 (1995) 1491-1495
36. McMichael A.J., and Giles G.G. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?. Br J Cancer 73 7 (1996) 945-950
37. Kraemer K.H., Lee M.M., Andrews A.D., and Lambert W.C. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130 8 (1994) 1018-1021
38. Smedby K.E., Hjalgrim H., Melbye M., et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97 3 (2005) 199-209
39. Hemminki K., Jiang Y., and Steineck G. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?. Eur J Cancer 39 2 (2003) 223-229
40. Ylikomi T., Laaksi I., Lou Y.R., et al. Antiproliferative action of vitamin D. Vitam Horm 64 (2002) 357-406
41. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence?. Br J Nutr 89 5 (2003) 552-572
42. de Vries E., Soerjomataram I., Houterman S., Louwman M.W., and Coebergh J.W. Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation?. Am J Epidemiol 165 8 (2007) 966-972
43. Grant W.B. A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: Additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol 103 3-5 (2007) 668-674